ArticleFrontiers in neuroscience2026
Hypoxia-induced OPN5 expression is associated with matrix-preserving responses in human scleral fibroblasts.
Article in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Myopia-associated scleral remodeling is characterized by altered extracellular matrix (ECM) turnover and progressive biomechanical weakening, processes that have been increasingly linked to scleral hypoxia. Opsin 5 (OPN5), a violet light-sensitive opsin, has been implicated in ocular growth regulation, but its role in scleral fibroblasts remains largely unknown. This study investigated the expression of OPN5 in human scleral fibroblasts (HSFs) under hypoxic conditions and examined its association with remodeling-related cellular responses. Methods: Primary HSFs were cultured under hypoxia (2% O Results: Exposure to hypoxic conditions resulted in progressive upregulation of OPN5 at both the transcript and protein levels and was accompanied by reduced COL1A1 and TIMP2 expression together with increased MMP2 and α-SMA expression, consistent with a remodeling-associated phenotype. Violet light further enhanced OPN5 expression under hypoxic conditions and was associated with partial restoration of COL1A1 and TIMP2 expression, together with reduced MMP2 and α-SMA expression levels. OPN5 overexpression was associated with increased COL1A1 and TIMP2 expression and decreased MMP2 and α-SMA expression, whereas CRISPR/Cas9-mediated reduction of endogenous OPN5 was associated with decreased COL1A1 and TIMP2 together with increased α-SMA expression. Transcriptomic analysis suggested potential associations between OPN5 expression and pathways related to extracellular matrix regulation, metabolism, Wnt signaling, and cytokine responses. Conclusion: OPN5 expression was increased in human scleral fibroblasts under hypoxic conditions and was associated with molecular signatures consistent with extracellular matrix preservation and reduced fibroblast activation. Violet light further enhanced OPN5 expression and was associated with partial attenuation of hypoxia-associated remodeling changes. These findings suggest that OPN5 is a hypoxia-responsive factor in scleral fibroblasts and support a context-dependent association between OPN5 signaling and extracellular matrix homeostasis under conditions relevant to myopia-associated scleral remodeling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.